The RNA replication machinery of HCV is a multi-subunit membrane-associated complex. NS5A has emerged as an active component of HCV replicase, possibly involved in regulation of viral replication and resistance to the antiviral effect of interferon. We report here substituted piperazinyl-N-(aryl)benzamides as potent inhibitors of HCV replication exerted via modulation of the dimerization of NS5A
AbstractA number of nucleotide and non-nucleoside inhibitors of HCV polymerase are currently under i...
The NS5B RNA-dependent RNA polymerase is an attractive target for the development of novel and selec...
AbstractThe hepatitis C virus (HCV) non-structural (NS) 5A protein plays an essential role in the re...
AbstractA series of novel amino-substituted N-aryl benzamide analogs were synthesized and evaluated ...
Here we report the discovery of a series of potent hepatitis C virus (HCV) NS5A inhibitors based on ...
Aminoquinolines and piperazines, linked or not, have been used successfully to treat malaria, and so...
International audienceAminoquinolines and piperazines, linked or not, have been used successfully to...
The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus r...
Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel ...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against he...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against h...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against h...
Chronic hepatitis C virus (HCV) infection is the leading cause of chronic liver disease. Current the...
The exogenous control of hepatitis C virus (HCV) replication can be mediated through the inhibition ...
A structure-based virtual screening of commercial compounds was carried out on the HCV NS3 helicase ...
AbstractA number of nucleotide and non-nucleoside inhibitors of HCV polymerase are currently under i...
The NS5B RNA-dependent RNA polymerase is an attractive target for the development of novel and selec...
AbstractThe hepatitis C virus (HCV) non-structural (NS) 5A protein plays an essential role in the re...
AbstractA series of novel amino-substituted N-aryl benzamide analogs were synthesized and evaluated ...
Here we report the discovery of a series of potent hepatitis C virus (HCV) NS5A inhibitors based on ...
Aminoquinolines and piperazines, linked or not, have been used successfully to treat malaria, and so...
International audienceAminoquinolines and piperazines, linked or not, have been used successfully to...
The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase (RdRp) plays a central role in virus r...
Infections caused by hepatitis C virus (HCV) are a significant world health problem for which novel ...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against he...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against h...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against h...
Chronic hepatitis C virus (HCV) infection is the leading cause of chronic liver disease. Current the...
The exogenous control of hepatitis C virus (HCV) replication can be mediated through the inhibition ...
A structure-based virtual screening of commercial compounds was carried out on the HCV NS3 helicase ...
AbstractA number of nucleotide and non-nucleoside inhibitors of HCV polymerase are currently under i...
The NS5B RNA-dependent RNA polymerase is an attractive target for the development of novel and selec...
AbstractThe hepatitis C virus (HCV) non-structural (NS) 5A protein plays an essential role in the re...